Table 1 |
|||||
|
Antibodies used for the immunohistochemical examination |
|||||
|
Antibody |
Clone |
Source |
Dilution |
Antigen retrieval |
Interpretation |
|
|
|||||
|
CD44 extracellular domain (aminoterminal end) |
Polyclonal, Ab64929 |
Abcam, Cambridge, MA |
1/50 |
Not applied |
Sinicrope's method* |
|
Zo-1 |
Polyclonal, 61-7300 |
Zymed, South San Francisco, CA |
1/100 |
Protease treatment (15 min, 37°C) |
Linear or dot-like |
|
Occludin |
Polyclonal, 71-1500 |
Zymed |
1/100 |
Protease treatment (15 min, 37°C) |
Linear or dot-like |
|
MMP-7 |
Monoclonal, 141-7B2 |
Daiichi Fine Chemical, Takaoka, Japan |
1/200 |
Microwave treatment for 15 min (Dako target retrieval solution [pH 6.0]) |
Sinicrope's method* |
|
Pancytokeratin |
Monoclonal, MNF116 |
Dakocytomation, Glostrup, Denmark |
1/50 |
Microwave treatment for 15 min (Dako target retrieval solution [pH 9.0]) |
For evaluation of tumor budding |
|
beta-Catenin |
Monoclonal, 14/beta-catenin |
BD Transduction laboratories, Lexington, KY |
1/200 |
Microwave treatment for 15 min (Dako target retrieval solution [pH 6.0]) |
Nuclear, more than 20% judged as positive; membranous and cytoplasmic, Sinicrope's method* |
|
Laminin-5γ2 |
Monoclonal, 4G1 |
Dakocytomation |
1/50 |
Microwave treatment for 15 min (Dako target retrieval solution [pH 6.0]) |
Sinicrope's method* |
|
Sialyl Lewis X |
Monoclonal, FH6 |
Ohtsuka Pharmaceutical, Tokushima, Japan |
1/2000 |
Microwave treatment for 15 min (Dako target retrieval solution [pH 6.0]) |
Sinicrope's method* |
|
|
|||||
|
• Sinicrope's method is described in Reference [27]. |
|||||
|
Mikami et al. Diagnostic Pathology 2011 6:30 doi:10.1186/1746-1596-6-30 |
|||||